Overcoming obstacles that hinder integration of real world data into current clinical development is becoming more critical. Yet organizations are limited by practical constraints (e.g. divergent business objectives, poor interface among stakeholders) and scientific boundaries (e.g. myopic focus on primary endpoints, early pipeline risk of candidate attrition). While there has been some investment into novel initiatives to further inform development, general application is a challenge. Ideally, the bridge between clinical and commercial is constructed with activities that ensure differentiation and adoption criteria are integrated earlier in development while clinical research insights are pushed forward to enrich launch planning and post market performance. This session takes a unique perspective, through the lens of a clinical program team, to demonstrate how pharma can improve hit rate and profitability; driving efficiencies in development, pricing optimally for the market, and increasing commercial value.

Ability Level: All

Session ID: 503589